 |
|
|
|
- Creapharm Developpement management wanted to buy this activity from its parent company Unither. AEC Partners was mandated by MPJA Holding, the manager's acquisition company, to assist the transaction
- Creapharm Developpement's main business is the galenic and analytic development and pharmaceutical manufacturing destined for clinical trials
- Main negociation issues, other than the valuation, were related to the carvel out its elf
|
